Biotech: Page 64
-
PharmaVoice Team/PharmaVoice
On the Calendar
On the Calendar April 17-19 Medical Manufacturing Summit The Homestead Resort, Hot Springs, Va. For more information, contact Caria Badenhorst, Marcus Evans, at 246-417-5321, e-mail [email protected], or visit medicalmanufacturingsummit.com. April 18-19 Neurodegeneration in Alzheimer’s, Pa...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Pharma’s Clouds Aren’t Darkening the Employee Recruitment Outlook Contributed by Julie B. Kampf Massive product safety recalls; costly accounting and pricing violations; embarrassing marketing and sales transgressions — is the beleaguered pharmaceutical sector an executive recruiter’s nightmare? ...
By Julie B. Kampf • Jan. 2, 2008 -
Explore the Trendlineâž”
Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
PharmaTrax
Drug Importation Poses Risks A federal HHS Task Force has warned in its Report on Prescription Drug Importation against the public health risks and economic effects of legalizing the importation of drugs from Canada and other countries with price controls. “This study confirms the deep flaws inhe...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Chief Risk Officers: Time for a Seat at The Table
VIEW on risk management Chief Risk Officers Time for a Seat at the Table In the wake of year one Sarbanes-Oxley compliance for U.S. public companies, there are greater challenges and increased expectations in addressing enterprise risk. Yet, compliance is not a matter of completing a one-year pro...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Biotech Drugs Will Be Hard Hit By Benefit Management Biologicals, which have received minimal pharmacoeconomic scrutiny from payers, increasingly will face the same strict value-based review and administration processes of pharmaceuticals, according to a 2005 study from The Bruckner Group Inc. (B...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Dr. Mark Ahn -- Poetic Science
Mark Ahn — Poetic Science For Mark Ahn, Ph.D., leadership is less about the power of one individual and more about the creation of heroic teams. Using a mix of literature, history, and traditional business skills, Dr. Ahn has found ways to unlock the imagination of his colleagues and employees at...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Prioritizing the Pipeline: The Critical Role of Porfolio Management
Prioritizing the Pipeline The critical role of portfolio management Increased pressures on the pharmaceutical industry – shrinking pipelines, rising costs, reimbursement issues, regulatory pressures, and consumer demands – mean companies have to find ways to focus on the projects that will meet c...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New electronic and web-based applications, sites, and technologies Solutions From PHT Provide Clinical Trial Savings and Flexibility Two recently launched offerings from PHT Corp., LogPad Phone and the Technology Transfer Program, aim to make the electronic capture of clinical-trial information e...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, marketing, And R&D Trends affecting the healthcare industry Profitable Biotech Companies Predicted to double in Next Few Years Therapeutic proteins and therapeutic antibodies collectively comprise almost 75% of biotech drugs currently on the market. Protein drugs also represent one of ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
executive appointments and promotions in the healthcare industry Pharma POOL Robert Boisclair Dr. Richard Bowles Steve Chellevold Mary-Frances Faraji Brent Saunders Schering-Plough Announces Senior-Level Management Changes Schering-Plough, Kenilworth, N.J., has made senior-level management change...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Value of Phase IV
BY Elisabeth Pena The Value of Phase IV Postmarketing research can be crucial for tracking side effects and exploring new uses for an approved drug. But these trials are heavily scrutinized because some say pharma companies have conducted such studies purely for promotional purposes with little s...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
talent pool executive appointments and promotions in the healthcare industry Pharma POOL Robert Bertolini Schering-Plough Appoints Executive VP, Chief Financial Officer Schering-Plough has appointed Robert J. Bertolini as executive VP and chief financial officer. He also serves on the Schering-Pl...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s new New healthcare-related products, services, and companies RxPedite Established to Provide Solutions to Emerging pharma and Biotech Companies Cardinal Health and inChord joint venture offers a full range of of launch-support services. RxPedite LLC has been established to provide comprehe...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
ROI on the Internet
By Elisabeth Pena ROI Return on the Internet The ability for pharma marketers to track online consumers’ reactions to Internet advertising is limited, but as the medium matures, tools are evolving to make it easier to measure return on investment. John Racik The days of click-throughs and banner ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Dr. Victoria Hale: Hale to a Champion
Hale to a champion By Kim Ribbink Dr. Victoria Hale, who both conceptualized and founded a nonprofit pharmaceutical company, is a true pioneer. Her goal is to create affordable, safe, and efficacious treatments for infectious diseases that affect millions in developing nations. Already, her compa...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
January 10-11 Clarifying the Regulatory Framework of Pharmaceutical Marketing Philadelphia For more information, contact Anne Marie Coluccio, PTi international, at 212-661-3500 ext. 3229, e-mail [email protected], or visit pti-international.com. January 24-25 Manage the Cost of Spec...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
CNS: A Complex Therapeutic and Patient-Recruitment Market
CNS By Lisa Dress A Complex Therapeutic and Patient-Recruitment Market An explosion of new science is leading to potential compounds to treat CNS diseases. The challenge for pharmaceutical companies and their partners is recruiting and retaining patients for trials. Understanding the brain and ho...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Coaching: Developing a Playbook for Sales Rep Success
pharmaceutical sales managers need to be taught how to hone their own coaching and counseling skills, as well as have a clear corporate direction to understand what is required from their people. An array of tools exist to help them to improve performance. Given the right coaching, the coach or m...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Creating Effective Outsourcing Partnerships
Creating Effective Outsourcing Partnerships By Denise Myshko Pharmaceutical companies are adopting a more strategic approach to outsourcing clinical-research services. Contract research outsourcing has grown exponentially over the past 30 years. In the 1970s, outsourcing was limited to preclinica...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s New New healthcare-related products, services, and companies Brand Institute Establishes New Subsidiary to Minimize Medication Errors The FDA’s Jerry Phillips joins private sector to continue risk-management work. Brand Institute has launched a new subsidiary – Drug Safety Institute (DSI) ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma trax Sales, marketing, And R&D Trends affecting the healthcare industry World Pharma Market Continues to Grow Amid Shifting Trends and Emerging Markets Though the pharmaceutical industry remains one of the most profitable and stable industries, several broad variables are leading to fu...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Obesity: A Market in Need of a Solution
Obesity A Market in Need of a Solution By Denise Myshko with a potentially open market for drugs to treat obesity and related diseases, pharmaceutical companies not only have to provide a pharmacological solution but also address the life-style issues associated with the disease and develop safe ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool Executive Appointments and Promotions in the Healthcare Industry Pharma POOL Dr. Ian McInnes Dr. Cecil B. Pickett Schering-Plough Announces Executive Appointments Schering-Plough, Kenilworth, N.J., a research-based company engaged in the discovery, development, manufacturing, and mark...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Managing Outcomes
Managing Outcomes BY ELISABETH PENA Limits on reimbursement for prescription drugs are expected to have a long-term impact on drug development. to address payer concerns, companies will need to have data on cost versus utility, and those data come from outcomes studies. But if they are to use suc...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The State of CME: Light at the End of the Tunnel
The State of CME light at the end of the tunnel BY ELISABETH PENA Conservatism has marked the pharmaceutical industry’s approach to CME following last year’s release of OIG guidelines, which suggest that manufacturers should take the programs out from under marketing and sales. The industry waits...
By PharmaVoice Team • Jan. 2, 2008
Previous
